Immunomodulation Is the Key to Cardiac Repair

Circ Res. 2017 May 12;120(10):1530-1532. doi: 10.1161/CIRCRESAHA.117.310954.

Authors

Tariq Hamid¹, Sumanth D Prabhu²

Affiliations

¹ From the Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, and Medical Service, Birmingham VAMC.
² From the Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, and Medical Service, Birmingham VAMC. sprabhu@uab.edu.

No abstract available

Keywords: Editorials; cell therapy; immunomodulation; inflammation; mesenchymal stem cells; myocardial infarction.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Anti-Inflammatory Agents
Cardiomyopathies*
Humans
Immunomodulation
Mesenchymal Stem Cells*
Myocardial Infarction*
Ventricular Dysfunction, Left*

Substances

Anti-Inflammatory Agents

Grants and funding